AAD 2026Abstract 72984
Consistency of Skin Clearance With the Targeted Oral Peptide Icotrokinra
Results From a Large Pooled Cohort of Phase 3 Study Participants With Moderate-to-Severe Plaque Psoriasis
Gold LS, Armstrong AW, Soung J, Vender RB, Pink AE, Cafone J, Edem BE, Reyes-Servin O, Li S, Yang YW, Lebwohl MG
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.517 · Not in PubMed: details from Crossref